Back to search

Article

Alterations in intestinal Proteobacteria and antimicrobial resistance gene burden in individuals administered microbial ecosystem therapeutic (MET-2) for recurrent <i>Clostridioides difficile</i> infection

2022-11-04

Abstract excerpt

Intestinal colonisation with pathogens and antimicrobial resistant organisms (AROs) is associated with increased risk of infection. Fecal microbiota transplant (FMT) has successfully been used to cure recurrent Clostridioides difficile infection (rCDI) and to decolonise intestinal AROs. However, FMT has significant practical barriers to implementation. A microbial consortium, microbial ecosystem therapeutic (MET)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ff15d4da-6398-59c9-975b-2808a9670992
DOI
10.1101/2022.11.04.515081
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alterations in intestinal Proteobacteria and antimicrobial resistance gene burden in individuals administered microbial ecosystem therapeutic (MET-2) for recurrent <i>Clostridioides difficile</i> infectionDOI 10.1101/2022.11.04.515081
A microbial consortium alters intestinal Pseudomonadota and antimicrobial resistance genes in individuals with recurrent Clostridioides difficile infectionSemantic proximity
Impact of a Purified Microbiome Therapeutic on Abundance of Antimicrobial Resistance Genes in Patients With RecurrentClostridioides difficileInfectionSemantic proximity
Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent <i>Clostridium difficile</i> InfectionSemantic proximity
Fecal Transplant in Children With Clostridioides difficile Gives Sustained Reduction in Antimicrobial Resistance and Potential Pathogen BurdenSemantic proximity
Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent <i>Clostridium difficile</i> infectionSemantic proximity
Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.Semantic proximity
Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD studySemantic proximity
Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trialSemantic proximity
Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trialSemantic proximity
Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infectionSemantic proximity
Emergent metabolic interactions in resistance to <i>Clostridioides difficile</i> invasionSemantic proximity
Slow and incomplete recovery of gut microbiome in Clostridioides difficile patients treated with metronidazoleSemantic proximity
Select a neighboring publication to make it the new centre.